(MENAFN- GlobeNewsWire - Nasdaq) Target high-growth services and invest in click chemistry, single-cell analysis and diagnostics to capture demand across proteomics and personalized medicine.Dublin, Nov. 05, 2026 (GLOBE NEWSWIRE) -- "Protein Labeling - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering.
The global protein labeling market was valued at US$2.8 billion in 2025 and is projected to reach US$5.1 billion by 2032, expanding at a compound annual growth rate (CAGR) of 8.7%. Market growth is being supported by advances in proteomics, cell biology, clinical diagnostics, single-cell analysis and targeted therapeutic development.
Protein Labeling Market Trends and Growth Drivers
Rising demand for precise, sensitive and versatile research technologies is accelerating the adoption of protein labeling across pharmaceutical and biotechnology companies, contract research and manufacturing organizations, and academic research institutions. Protein labeling supports critical applications such as immunological techniques, cell-based assays, fluorescence microscopy, protein microarrays and mass spectrometry.
Technological innovation remains a central market driver. Advances in click chemistry are improving labeling selectivity in complex biological environments, while genetically encoded tags, including green fluorescent protein and related derivatives, enable real-time protein visualization in living cells. Mass spectrometry-compatible technologies, including isotope-coded affinity tags and tandem mass tags, are also strengthening quantitative protein expression and post-translational modification analysis.
Emerging opportunities in proteomics, synthetic biology and single-cell research are further broadening the market. Highly sensitive labeling methods are increasingly required to analyze protein interactions and quantify proteins at the cellular level. In clinical diagnostics, protein labeling is contributing to the development of advanced assays and imaging technologies for diseases such as cancer and neurodegenerative disorders. Growing investment in personalized medicine and targeted therapies is expected to reinforce demand throughout the forecast period.
Market Segment Outlook
Component: Reagents and kits; services. Method: In-vitro labeling; in-vivo labeling. Application: Immunological techniques, cell-based assays, fluorescence microscopy, protein microarrays and mass spectrometry. End Use: Pharmaceutical and biotechnology companies, contract research and manufacturing organizations, academic and research institutes, and other end users.
The reagents and kits segment is forecast to reach US$2.9 billion by 2032, growing at a CAGR of 7%. The services segment is expected to record stronger growth, advancing at a CAGR of 11.4% during the analysis period as organizations increasingly seek specialized expertise and outsourced research capabilities.
Regional Protein Labeling Market Analysis
The United States protein labeling market was valued at US$828.4 million in 2025, supported by extensive life sciences research, pharmaceutical innovation and advanced laboratory infrastructure. China is forecast to expand at an 8.4% CAGR and reach US$899.8 million by 2032. The report also evaluates market trends across Canada, Japan, Germany, France, Italy, the United Kingdom, the rest of Europe, Asia-Pacific and the rest of the world.
Report Scope and Strategic Value
The report provides independent analysis of annual protein labeling sales and market forecasts from 2025 through 2032. It examines the competitive environment, regional market dynamics, technology adoption, emerging opportunities and factors influencing demand. The analysis is designed to help organizations evaluate growth priorities, identify revenue opportunities and support informed strategic decisions.
Comprehensive global, regional and segment-level market forecasts. Analysis of key trends, growth drivers, restraints and technology developments. Competitive intelligence covering market presence across major geographies. Assessment of high-growth components, methods, applications and end-use sectors. Company profiles and strategic analysis of leading protein labeling market participants. Complimentary report updates for one year.
Key Questions Addressed
How will the global protein labeling market evolve through 2032? Which technologies and applications will generate the strongest growth? What factors are driving or restraining market expansion? How will regional and segment shares change during the forecast period? Which companies are shaping the competitive landscape?
Companies Featured
F. Hoffmann-La Roche AG General Electric Company Kaneka Corporation LI-COR, Inc. (LI-COR Biosciences) Merck KGaA New England Biolabs, Inc. PerkinElmer, Inc. Promega Corporation SeraCare Life Sciences, Inc. Thermo Fisher Scientific, Inc.
Domain Expert Insights
The report incorporates perspectives from domain experts across industry, enterprise and academia, providing context beyond conventional secondary research. The report tracks early market signals emerging from expert discussions, company activity, conference sessions, keynote presentations, panel discussions, corporate disclosures, annual reports, institutional publications and other validated sources.
These insights are synthesized to identify strategic market direction, competitive developments and technologies likely to influence future investment. The analysis also extends beyond market-level findings to assess the companies shaping the competitive environment. Where relevant, market share is examined by major region to reflect differences in local competitive structures rather than relying solely on a single global figure.
Key Attributes:
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment